Skip to content
All Updates
- Notification of Fee in respect of Regulatory Functions of DRAPMarch 11, 2026
- 05. Recall Alert (Class-I) – CDL declared substandard – Teczone Forte InjectionFebruary 25, 2026
- Circulars for Submission of Summary of Product Characteristics (SmPC) and Risk Management Plans (RMP)February 24, 2026
- 04. Rapid Alert – “Zetol” Unregistered Antiseptic productFebruary 18, 2026
- Minutes of the 117th, 118th, 119th, and 120th Meetings of the Medical Device Board (MDB)February 16, 2026
- 03. Recall Alert (Class-I) – Veterinary Drug Products reports from DTLs Punjab.February 12, 2026
- 02. Recall Alert (Class-II) – Drug Products tested by DTL PunjabFebruary 12, 2026
- 01. Recall Alert (Class-I) – Drug Products tested by DTL Punjab.February 12, 2026
- Safety Alert of Risk of severe itching after discontinuation of long-term use of Cetirizine and LevocetirizineFebruary 9, 2026
- Minutes of 353rd Meeting of Registration Board (14th – 15th January, 2026)February 6, 2026
- Safety Alert of Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) with SemaglutideFebruary 6, 2026
- Safety Alert of Risk of Circulatory Shock with the Sulfamethoxazole and trimethoprim drug combinationFebruary 6, 2026
- Safety Alert of Potential Risk of Suicidal Thoughts with Finasteride and Dutasteride-containing medicinesFebruary 3, 2026
- Safety Alert of Risk of Intrahepatic Cholestasis of Pregnancy with ThiopurinesFebruary 3, 2026
- Safety Alert of Risk of Idiopathic Intracranial Hypertension with MesalazineJanuary 30, 2026
- Safety Alert of Risk of Sacroiliitis with IsotretinoinJanuary 30, 2026
- Guidance Document for Submission of Applications on Form-5F (CTD) for Registration of Pharmaceutical Drug Products for Human UseJanuary 30, 2026
- 136. Rapid Alert – Spurious Tablet EFASTON – Batch # 51062January 23, 2026
- Training session for medical device stakeholders on the MDMC licensing and product registration portalJanuary 22, 2026
- 134. Recall Alert (Class-II) – CDL declared substandard – Henafim Paediatric SuspensionJanuary 21, 2026
- 135. Rapid Alert – Unregistered OMNIVISC 2% (Substandard & Misbranded)January 21, 2026
- Decisions of the 115th and 116th Meetings of the Medical Device Board (MDB) held on 01 & 07 Jan 2026 (Manual Applications – Part II)January 21, 2026
- Minutes of the 6th Meeting of the Pharmacovigilance Risk Assessment Expert Committee (PRAEC)January 21, 2026
- 133. Recall Alert (Class-I) – Tablet BP-NORM (Substandard & Adulterated)January 21, 2026
- Public Consultation: Guidance Document for Submission of Application on Form-5F (CTD) for Registration of Biological Products for Human Use – 2nd Edition.January 20, 2026
- Invitation for Stakeholders’ Comments on Draft Amendments in the Bio-Study Rules, 2017January 19, 2026
- 132. Recall Alert – Veterinary Products – Substandard by DTLs Punjab.January 14, 2026
- 131. Recall Alert (Class-II) – DTLs Punjab Declared Substandard products.January 14, 2026
- 130. Recall Alert – Drug Testing Laboratories, Punjab – Substandard products.January 14, 2026
- 129. Recall Alert(Class-I) – DIFAM Injection 3ml (Bosch Pharma) – SubstandardJanuary 14, 2026
- 128. Rapid Alert – Eventone-C Creams & LUFA Advanced Pain Relief Gel Containing Unauthorized Pharmaceutical Ingredient(s)January 14, 2026
- Capacity building and technical awareness session on 2D Barcode & Serialization and harmonized report writing performa for inspection of pharmaceutical units (Session in Peshawar)January 8, 2026
- Capacity building and technical awareness session on 2D Barcode & Serialization and harmonized report writing performa for inspection of pharmaceutical unitsJanuary 6, 2026
- Minutes of the 113th & 114th Meetings of the Medical Device BoardJanuary 6, 2026
- 127. Rapid Alert – Falsified Duphalac Syrup (Batch # 251986127 )December 30, 2025
- 126. Recall Alert (Class-I) – Injection Cara-Doba 5ml – SubstandardDecember 30, 2025
- 125. Rapid Alert – Crackdown Against Falsified / Spurious/ Unregistered Aphrodisiac Drug Products.December 30, 2025
- 124. Rapid Alert – Crackdown Against Unlicensed / Unauthorized Manufacturers.December 30, 2025
- Requirements for Grant of Drug Manufacturing License by the Way of Basic and Semi-Basic Manufacturing for Blood/Plasma EstablishmentsDecember 29, 2025
- Decisions of the 112th Meeting of the Medical Device Board (MDB) Held on 11-12-2025 (Manual Application – Part II)December 29, 2025
- Minutes of 352nd Meeting of Registration BoardDecember 24, 2025
- Training on software for electronic submission of applications for issuance of Nothing Due Certificate(NDC) on account of central research fund.December 24, 2025
- Training on online module for issuance of CRF-Nothing Due Certificate(NDC) By MIS Division, DRAP (For all pharmaceutical industry)December 23, 2025
- Quota Allocation of Drug Substance for Product Development StudiesDecember 22, 2025
- 123. Recall Alert (Class-I) – Drug Products (Human) Substandard – Gligit Baltistan.December 18, 2025
- 122. Rapid Alert – Falsified / Spurious / Unregistered Tramadol Tablets.December 18, 2025
- 120. Recall Alert (Class-I) – Drug Products (Human) Substandard by DTL Punjab.December 16, 2025
- 119. Recall Alert (Class-II) – Drug Products (Human) Substandard -DTL PunjabDecember 16, 2025
- Decisions of the 110th Meeting of the Medical Device Board (MDB) held on 26-11-2025 & 27-11-2025 (Manual Applications – Part II)December 15, 2025
- Tender for Conducting a National Pharmaceutical Pricing SurveyDecember 14, 2025